NCT02211560

N/AInterventional

Trials without FDA-defined phases, including trials of devices or behavioral interventions.

View on ClinicalTrials.gov ↗

Timeline

Start date: Sep 30, 2014
Primary completion: Dec 25, 2017
Completion date: Dec 25, 2017
First posted: Aug 7, 2014
Last posted: Feb 5, 2018
Enrollment: 97
Arms / groups: 2 / —
Source: AACT · ctgov ingestion

Drugs studied

phosphatidylserine

Indications studied

Cognitive Dysfunction

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.

NCT02211560

Timeline

Sponsors

Drugs studied

Indications studied